Effectiveness of Modern Physical Agents in the Treatment of Pelvic Floor Dysfunctions

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorLithuanian University of Health Sciences

About this trial

This clinical trial aims to determine whether adding modern physical agents (high-intensity laser therapy, magnetotherapy, radial shock wave therapy, kinesiotaping) in conjunction with classical rehabilitation interventions produces superior outcomes in treating pelvic floor dysfunction compared to classical rehabilitation interventions alone. It will also assess the safety of these agents in the context of pelvic floor dysfunction rehabilitation. The main questions it aims to answer are:

Does adding modern physical agents to the treatment of pelvic floor dysfunction improve symptoms, impairments in functional state, quality of life, and biosocial functions more effectively than classical interventions alone?

Participants who experience pelvic floor dysfunction during primary rehabilitation will receive:

Either an individualized rehabilitation intervention plan comprising 20 classical procedures in combination with modern physical agents or classical interventions alone. Rehabilitation will take place in the outpatient rehabilitation department. Patients will visit the clinic for a comprehensive functional state assessment and then for individualized procedures; the entire plan will be delivered over three months, after which participants will return for follow-up checkups and assessments after the procedures and again after six months.

Eligibility criteria

Qualifiers

Patients older than 18 years old.

One or more signs characteristic of pelvic floor dysfunctions are identified: elimination function disorders, pelvic organ prolapse, scar(s) (and lack of tissue mobility) in the perineum, pelvic floor muscle tone/strength disorders (hypoactivity/hyperactivity), neuromuscular control disorders, sexual dysfunctions, pain in the pelvis, perineum.

Not a single exclusion criterion has been established.

Subjects capable of signing informed consent.

Disqualifiers

Oncological diseases or being actively investigated for oncological diseases.

Any contraindications to methods of functional state examination or physical agents in the pelvic area that will be used in the study

Individuals who refuse a detailed clinical examination of the perineum and pelvic floor muscles, functional testing, and/or functional ultrasound examination.

Patients with urinary tract, prostate, genital, and other infections.

Trial design

Treatments tested in this trial

  • modern agents rehab
  • classical rehab

Treatment groups

250 Participants
are divided into 2 treatment groups